Grading urothelial carcinoma with probe-based confocal laser endomicroscopy during flexible cystoscopy.


Journal

World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716

Informations de publication

Date de publication:
27 Jul 2024
Historique:
received: 05 04 2024
accepted: 09 06 2024
medline: 28 7 2024
pubmed: 28 7 2024
entrez: 27 7 2024
Statut: epublish

Résumé

Urothelial bladder cancer (UCB) care requires frequent follow-up cystoscopy and surgery. Confocal laser endomicroscopy (CLE) is a probe-based optical technique that can provide real-time microscopic evaluation with the potential for outpatient grading of UCB. This study aims to investigate the diagnostic accuracy and interobserver variability for the grading of UCB with CLE during flexible cystoscopy (fCLE). Participants scheduled for transurethral resection of papillary bladder tumors were prospectively included for intra-operative fCLE. Exclusion criteria were flat lesions, fluorescein allergy or pregnancy. Two independent observers evaluated fCLE, classifying tumors as low- or high-grade urothelial carcinoma (LGUC/HGUC) or benign. Interobserver agreement was calculated with Cohens kappa (κ) and diagnostic accuracy with 2 × 2 tables. Histopathology was the reference test. Histopathology of 34 lesions revealed 14 HGUC, 14 LGUC and 6 benign tumors. Diagnostic yield for fCLE was 80-85% with a κ of 0.75. Respectively, sensitivity, specificity, NPV and PPV were: for benign tumors 0-20%, 96-100%, unmeasureable-50% and 87%, for LGUC 57-64%, 41-58%, 44-53% and 54-69% and for HGUC 38-57%, 56-68%, 38-57% and 56-68%, with an interobserver agreement of κ 0.61. fCLE is currently insufficient to grade UCB.

Identifiants

pubmed: 39066902
doi: 10.1007/s00345-024-05122-x
pii: 10.1007/s00345-024-05122-x
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

450

Subventions

Organisme : KWF Kankerbestrijding
ID : KWF Kankerbestrijding
Organisme : Cure for Cancer Foundation
ID : Cure for Cancer Foundation

Informations de copyright

© 2024. The Author(s).

Références

Cancer IAfRo WHO Classification of Tumours Editorial Board. Urinary and male genital tumours. 2022 22-3-2022. In: WHO classification of tumours series [Internet]. Lyon (France). 5th. https://tumourclassification.iarc.who.int/chapters/36
Sylvester RJ, van der Meijden AP, Oosterlinck W, Witjes JA, Bouffioux C, Denis L et al (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49(3):466–467
doi: 10.1016/j.eururo.2005.12.031 pubmed: 16442208
Botteman MF, Pashos CL, Redaelli A, Laskin B, Hauser R (2003) The Health Economics of bladder Cancer: a Comprehensive Review of the published literature. PharmacoEconomics 21(18):1315–1330
doi: 10.1007/BF03262330 pubmed: 14750899
Erikson MS, Petersen AC, Andersen KK, Jacobsen FK, Mogensen K, Hermann GG (2020) Do repeated transurethral procedures under general anesthesia influence mortality in patients with non-invasive urothelial bladder cancer? A Danish national cohort study. Scand J Urol 54(4):281–289
doi: 10.1080/21681805.2020.1782978 pubmed: 32584153
Freund JE, Savci-Heijink CD, Kamphuis GM, de la Rosette JJMCH, Liem EIML, de Bruin DM, Baard J Confocal laser endomicroscopy for upper tract urothelial carcinoma: validation of the proposed criteria and proposal of a scoring system for real-time tumor grading. W J Urol. 2019(0123456789).
Breda A, Territo A, Guttilla A, Sanguedolce F, Manfredi M, Quaresima L et al (2018) Correlation between Confocal Laser Endomicroscopy (Cellvizio((R))) and histological grading of Upper Tract Urothelial Carcinoma: a Step Forward for a Better Selection of Patients Suitable for Conservative Management. Eur Urol Focus 4(6):954–959
doi: 10.1016/j.euf.2017.05.008 pubmed: 28753800
Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L et al (2015) STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. Clin Chem 61(12):1446–1452
doi: 10.1373/clinchem.2015.246280 pubmed: 26510957
Liem EIML, Freund JE, Savci-Heijink CD, de la Rosette JJMCH, Kamphuis GM, Baard J et al (2018) Validation of Confocal Laser Endomicroscopy features of bladder Cancer: the next step towards real-time histologic grading. Eur Urol Focus
Chang TC, Liu J-J, Hsiao ST, Pan Y, Mach KE, Leppert JT et al (2013) Interobserver Agreement of Confocal laser endomicroscopy for bladder Cancer. J Endourol 27(5):598–603
doi: 10.1089/end.2012.0549 pubmed: 23072435 pmcid: 3643225
Sedrakyan A, Campbell B, Merino JG, Kuntz R, Hirst A, McCulloch P (2016) IDEAL-D: a rational framework for evaluating and regulating the use of medical devices. BMJ (Clinical Res ed) 353:i2372
Lee J, Jeh SU, Koh DH, Chung DY, Kim MS, Goh HJ et al (2019) Probe-based confocal laser Endomicroscopy during Transurethral resection of bladder tumors improves the diagnostic accuracy and therapeutic efficacy. Ann Surg Oncol 26(4):1158–1165
doi: 10.1245/s10434-019-07200-6 pubmed: 30719635 pmcid: 6399171
Lucas M, Liem E, Savci-Heijink CD, Freund JE, Marquering HA, van Leeuwen TG, de Bruin DM (2019) Toward automated in vivo bladder tumor stratification using Confocal Laser Endomicroscopy. J Endourol 33(11):930–937
doi: 10.1089/end.2019.0354 pubmed: 31657629
Wu J, Wang YC, Dai B, Ye DW, Zhu YP (2019) Optical biopsy of bladder cancer using confocal laser endomicroscopy. Int Urol Nephrol 51(9):1473–1479
doi: 10.1007/s11255-019-02197-z pubmed: 31214952
May M, Brookman-Amissah S, Roigas J, Hartmann A, Storkel S, Kristiansen G et al (2010) Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organisation classifications. Eur Urol 57(5):850–858
doi: 10.1016/j.eururo.2009.03.052 pubmed: 19346063
Bonnal JL, Rock A, Gagnat A, Papadopoulos S, Filoche B, Mauroy B (2012) Confocal laser endomicroscopy of bladder tumors associated with photodynamic diagnosis: an ex vivo pilot study. Urol 80(5):1162. e1-.e5
doi: 10.1016/j.urology.2012.06.035
Pan Y, Volkmer JP, Mach KE, Rouse RV, Liu JJ, Sahoo D et al (2014) Endoscopic molecular imaging of human bladder cancer using a CD47 antibody. Sci Transl Med 6(260):260ra148
doi: 10.1126/scitranslmed.3009457 pubmed: 25355698
Marien A, Rock A, Maadarani KE, Francois C, Gosset P, Mauroy B, Bonnal JL (2017) Urothelial tumors and Dual-Band imaging: a New Concept in Confocal Laser Endomicroscopy. J Endourol 31(5):538–544
doi: 10.1089/end.2016.0892 pubmed: 28326794
Kriegmair MC, Rother J, Grychtol B, Theuring M, Ritter M, Gunes C et al (2020) Multiparametric cystoscopy for detection of bladder Cancer using real-time multispectral imaging. Eur Urol 77(2):251–259
doi: 10.1016/j.eururo.2019.08.024 pubmed: 31563499

Auteurs

Ben-Max de Ruiter (BM)

Department of Urology, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands. b.deruiter@amsterdamumc.nl.
Cancer Center Amsterdam, Amsterdam, The Netherlands. b.deruiter@amsterdamumc.nl.
Department of Biomedical Engineering and Physics, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands. b.deruiter@amsterdamumc.nl.

Jan Erik Freund (JE)

Cancer Center Amsterdam, Amsterdam, The Netherlands.
Department of Pathology, UMC Utrecht, University of Utrecht, Heidelberglaan 100, Utrecht, The Netherlands.
Department of Pathology, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.

C Dilara Savci-Heijnink (CD)

Cancer Center Amsterdam, Amsterdam, The Netherlands.
Department of Pathology, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.

Jons W van Hattum (JW)

Department of Urology, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
Cancer Center Amsterdam, Amsterdam, The Netherlands.

Theo M de Reijke (TM)

Department of Urology, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
Cancer Center Amsterdam, Amsterdam, The Netherlands.

Joyce Baard (J)

Department of Urology, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
Cancer Center Amsterdam, Amsterdam, The Netherlands.

Guido M Kamphuis (GM)

Department of Urology, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
Cancer Center Amsterdam, Amsterdam, The Netherlands.

D Martijn de Bruin (DM)

Department of Urology, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
Cancer Center Amsterdam, Amsterdam, The Netherlands.
Department of Biomedical Engineering and Physics, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.

Jorg R Oddens (JR)

Department of Urology, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
Cancer Center Amsterdam, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH